Predictive role of CCND1, FGFR1 gene amplifications and PIK3CA mutations for endocrine therapy of primary metastatic breast cancer . Вопр. онкол. [Internet]. 2021 Oct. 29 [cited 2026 Oct. 14];67(5):646-57. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1220